Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study)
Eduardo Flores‐Umanzor, Pedro Cepas‐Guillén, Dabit Arzamendi, Ignacio Cruz‐González, Ander Regueiro, Xavier Freixa
Topics & Concepts
MedicineApixabanAntithromboticLeft atrial appendage occlusionClopidogrelRandomized controlled trialAtrial fibrillationAspirinStroke (engine)Internal medicineCardiologyMyocardial infarctionFibrinolytic agentClinical endpointSurgeryWarfarinRivaroxabanEngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiovascular Disease and Adiposity